- Do you, or did you, own shares of OvaScience, Inc. (NASDAQ GM: OVAS )?
- Did you purchase your shares before February 25, 2013, or between February 25, 2013 and September 10, 2013, inclusive?
- Did you lose money in your investment in OvaScience, Inc.?
- Do you want to discuss your rights?
On this news, shares in OvaScience dropped more than 23%, closing at $10.95 per share on September 11, 2013, on unusually heavy trading volume.If you wish to serve as lead plaintiff, you must move the Court no later than November 15, 2013. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation. In order to be appointed lead plaintiff, the Court must determine that the class member’s claim is typical of the claims of other class members, and that the class member will adequately represent the class. Your ability to share in any recovery is not, however, affected by the decision whether or not to serve as a lead plaintiff. Any member of the proposed class may move the court to serve as lead plaintiff through counsel of their choice, or may choose to do nothing and remain an absent class member. While Rigrodsky & Long, P.A. did not file the Complaint in this matter, the firm, with offices in Wilmington, Delaware and Garden City, New York, regularly litigates securities class, derivative and direct actions, shareholder rights litigation and corporate governance litigation, including claims for breach of fiduciary duty and proxy violations in the Delaware Court of Chancery and in state and federal courts throughout the United States. Attorney advertising. Prior results do not guarantee a similar outcome.